InvestorsHub Logo
Followers 7
Posts 1173
Boards Moderated 0
Alias Born 11/13/2018

Re: Atom0aks post# 224032

Sunday, 11/10/2019 11:09:39 AM

Sunday, November 10, 2019 11:09:39 AM

Post# of 424407
There is no comparison in these trials and you know it. Why did you not include the other non-diabetic population? You make it appear there would only be one question for one of the populations and make it appear negative. This other trial had over 40% of the patients discontinue because of side effects. That factors into how physicians would answer a questions and while we are at it 6% vs 12 % is very different.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News